Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Plaquenil® (hydroxychloroquine) – New warnings
January 27, 2017 – The FDA approved new updates to the Warnings section of the Plaquenil (hydroxychloroquine) drug label regarding cardiac effects, including cardiomyopathy and QT prolongation, and hypoglycemia.
